Articles

Why investors should care about Nvidia’s ‘very unusual’ relationship with CoreWeave

Nvidia is a significant investor in CoreWeave, and also sells the cloud company a lot of chips.

Scary headlines drive people to claim Social Security earlier – and that has real consequences

DOGE attack on Social Security sparks anxiety about program’s stability

China’s AI industry is booming. Can Nvidia and other U.S. companies still get in on it?

Chinese cloud providers have been big buyers of U.S. artificial-intelligence hardware. Jefferies analysts are upbeat that the trend can continue despite trade-war pressures.

Can I stop my Social Security benefits if I decide to take early retirement? 

Retirees may be able to change their minds on receiving Social Security benefits, but there are stipulations.

Jamie Dimon’s bond-market warnings put investors on alert to diversify outside U.S.

JPMorgan Chase & Co.’s chief executive, Jamie Dimon, came out on Monday with another warning about the bond market that some observers said could prompt more investors to look around the world and at other asset classes for protection.

Boeing CEO Ortberg is winning hearts on Wall Street. Here’s the latest vote of confidence.

Boeing’s stock could rise 25%, BofA analysts said, as the aerospace and defense giant works to break out of its “doom loop.”

20 stocks primed for rapid growth while trading at half of Nvidia’s valuation

When selecting investments, it is easy to get hung up on a particular metric, such as a dividend yield or a price ratio, but investors need to look deeper or they might miss opportunities.

Tesla sales plunge in France, showing Elon Musk may have a long way to go to restore the brand

Tesla’s sales have been under pressure in Europe, even after the rollout of a souped-up Model Y.

Popular ‘zero-day’ options saw record share of trading volume in May as retail traders piled in

The share of trading volume in S&P 500-linked options contracts on the verge of expiration surged to a fresh record high in May, marking the latest milestone in the growth of one of Wall Street’s most popular options strategies, according to data from Cboe Global Markets.

U.S. manufacturers get little relief from relaxed Trump tariffs — ‘what happens in 90 days?’

American manufacturers were among the first U.S. businesses to show damage from President Trump’s trade wars. And they are still showing lots of stress even after the White House relaxed most tariffs.

Don’t count on an inheritance: Baby boomers are hanging on to their money

How to tell your children you plan to “die with zero.”

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.
1 347 348 349 350 351 2,444